Literature DB >> 16082592

Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.

Go Kobayashi1, Naotaka Fujita, Yutaka Noda, Kei Ito, Jun Horaguchi, Osamu Takasawa, Satoshi Akaishi, Takashi Tsuchiya, Masao Kobari.   

Abstract

BACKGROUND: We investigated the mode of progression of intraductal papillary-mucinous neoplasm of the pancreas (IPMN) in patients who underwent follow-up in order to elucidate the characteristics of malignancy and to establish an effective treatment strategy.
METHODS: Fifty-one patients with IPMN (branch-duct type, 47; main-duct type, 4) who had undergone follow-up study by endoscopic ultrasonography (EUS) were included (mean follow-up duration, 41.0+/-32.3 months; average number of EUS examinations performed during follow-up, 4.4). Chronological changes in EUS findings and histological findings of resected specimens were evaluated.
RESULTS: Of the patients with the branch-duct type, only 2% showed enlargement of the dilated branches. In the main-duct-type group, an increase in size of the main pancreatic duct (MPD) was observed in 75% of the patients. In 14 patients with papillary protrusions, an increase in size and lateral spread was observed in 71% and 43%, respectively. No patients developed invasive cancer. In 15 patients who had thick septum-like structures (TSS), the development of papillary protrusions and that of invasive cancer were observed in 53% and 13%, respectively. Twenty-nine patients who had thin septum-like structures showed no change. Two patients with dense multilocular large cysts and TSS developed invasive cancer without change in the cystic lesions. One patient developed carcinoma with multifocal stromal invasion.
CONCLUSIONS: Patients with branch-duct type IPMNs without papillary protrusions or TSS are not immediate candidates for surgery. Those who have small papillary protrusions have a benign course. It is recommended that patients with the large branch-duct type with TSS should undergo surgery. Attention should be paid to the entire pancreas when performing follow-up examinations in patients with branch-duct type IPMN, as invasive ductal adenocarcinoma can develop at a site in the pancreas different from that of the IPMN.

Entities:  

Mesh:

Year:  2005        PMID: 16082592     DOI: 10.1007/s00535-005-1619-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.

Authors:  T Izawa; T Obara; S Tanno; Y Mizukami; N Yanagawa; Y Kohgo
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

2.  Evaluation of various imaging methods in the differential diagnosis of intraductal papillary-mucinous tumor (IPMT) of the pancreas.

Authors:  K Yamao; K Ohashi; T Nakamura; T Suzuki; Y Watanabe; Y Shimizu; Y Nakamura; I Ozden
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

3.  Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management.

Authors:  M Kobari; S Egawa; K Shibuya; H Shimamura; M Sunamura; K Takeda; S Matsuno; T Furukawa
Journal:  Arch Surg       Date:  1999-10

4.  Solitary cystic tumor of the pancreas: EUS-pathologic correlation.

Authors:  K Koito; T Namieno; T Nagakawa; T Shyonai; N Hirokawa; K Morita
Journal:  Gastrointest Endosc       Date:  1997-03       Impact factor: 9.427

5.  Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography.

Authors:  M Sugiyama; Y Atomi; M Saito
Journal:  Gastrointest Endosc       Date:  1998-08       Impact factor: 9.427

6.  Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor.

Authors:  Yutaka Suzuki; Yutaka Atomi; Masanori Sugiyama; Shuji Isaji; Kazuo Inui; Wataru Kimura; Makoto Sunamura; Toru Furukawa; Akio Yanagisawa; Jo Ariyama; Tadahiro Takada; Hidenobu Watanabe; Koichi Suda
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

7.  [Clinicopathological and diagnostic study of mucin producing pancreatic tumors].

Authors:  H Maguchi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-05

8.  Mucin-producing tumor of the pancreas--intraluminal ultrasonography.

Authors:  K Inui; S Nakazawa; J Yoshino; H Yamachika; N Kanemaki; T Wakabayashi; K Okushima; N Taki; Y Nakamura; T Takashima; T Hattori; H Miyoshi
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

9.  Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively.

Authors:  K Yamaguchi; Y Ogawa; K Chijiiwa; M Tanaka
Journal:  Am J Surg       Date:  1996-04       Impact factor: 2.565

10.  c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas.

Authors:  A Yanagisawa; Y Kato; K Ohtake; T Kitagawa; K Ohashi; M Hori; K Takagi; H Sugano
Journal:  Jpn J Cancer Res       Date:  1991-10
View more
  27 in total

1.  Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms.

Authors:  Jin Hee Lee; Kyu Taek Lee; Jongwook Park; Sun Youn Bae; Kwang Hyuck Lee; Jong Kyun Lee; Kee-Taek Jang; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.

Authors:  Kenji Yamao
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

3.  Growth process of small pancreatic carcinoma: a case report with imaging observation for 22 months.

Authors:  Takeshi Hisa; Hiroki Ohkubo; Satoshi Shiozawa; Hiroki Ishigame; Masato Takamatsu; Masayuki Furutake; Bunsei Nobukawa; Koichi Suda
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 4.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

5.  Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.

Authors:  Hirofumi Harima; Seiji Kaino; Shuhei Shinoda; Michitaka Kawano; Shigeyuki Suenaga; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

6.  Intraductal papillary mucinous neoplasms of the pancreas showing fistula formation into other organs.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Kei Ito; Jun Horaguchi; Takashi Obana; Shinsuke Koshida; Yoshihide Kanno; Yasunobu Yamashita; Yuhei Kato; Takahisa Ogawa; Masaya Oikawa; Takashi Tsuchiya; Takashi Sawai
Journal:  J Gastroenterol       Date:  2010-06-15       Impact factor: 7.527

7.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Seung-Mo Hong; David Kelly; Margaret Griffith; Noriyuki Omura; Ang Li; Chung-Pin Li; Ralph H Hruban; Michael Goggins
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

9.  Asymptomatic pancreatic lesions: new insights and clinical implications.

Authors:  Martin Loos; Christoph W Michalski; Jörg Kleeff
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 10.  Malignant potential of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Yoshiyuki Nakajima; Takatsugu Yamada; Masayuki Sho
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.